SLU-PP-332
A profile on the novel ERR-alpha agonist known as an "exercise mimetic," capable of boosting endurance and metabolism without movement.
SLU-PP-332
SLU-PP-332 is a cutting-edge research compound that falls into the category of "exercise mimetics." It is not a SARM and it is not a stimulant.
It is an agonist of the Estrogen-Related Receptor Alpha (ERRα). While the name implies estrogen, this receptor regulates metabolic pathways, specifically those related to mitochondrial function and endurance. It gained headlines for allowing mice to run 70% longer and 45% further than untreated mice without prior training.
Quick Specs
| Property | Value |
|---|---|
| Active Compound | SLU-PP-332 |
| Half-Life | Unknown (Likely short) |
| Detection Time | Unknown |
| Anabolic/Androgenic Ratio | N/A (Non-Hormonal) |
| Chemical Family | ERRα Agonist |
| Administration | Oral or Injectable |
Mechanism of Action
SLU-PP-332 activates ERRα. This receptor controls the transcription of genes involved in fatty acid oxidation (fat burning) and mitochondrial biogenesis.
Essentially, it tricks skeletal muscle into believing it is performing endurance exercise. It shifts the body's fuel preference from glucose to fatty acids and increases the number of type IIa oxidative muscle fibers.
Pharmacokinetics & Dosing
Half-Life: Short
Current research protocols and anecdotal logs suggest frequent dosing is best.
- Frequency: Daily (usually pre-cardio or in the morning).
- Dosage:
- Injectable: 10mg - 20mg per day.
- Oral: Bioavailability is debated; doses often range higher (25mg-50mg).
Primary Effects
1. Massive Endurance Boost
Users report effortless cardio sessions and reduced windedness during high-rep weight training.
2. Fat Loss (Calorie Deficit Support)
By upregulating fatty acid oxidation, it helps mobilize stubborn fat stores.
3. Muscle Preservation
Unlike Ozempic/Semaglutide which can cause muscle loss alongside fat loss, SLU-PP-332 appears to preserve lean muscle mass while stripping fat.
Side Effects & Harm Reduction
Novel Compound:
Lack of Data: Unlike Testosterone or even Ostarine, SLU-PP-332 is brand new. Long-term safety data in humans is non-existent. We do not know the long-term impact on the heart or liver.
1. Non-Hormonal
It does not suppress testosterone. No PCT needed.
2. No Appetite Suppression
Unlike GLP-1 agonists, it does not kill appetite. You must still discipline your diet.
Tracking SLU-PP-332
Using the Anabolic Tracker app:
- Inventory: Add SLU-PP-332.
- Scheduling: Daily.
- Metrics: Track Resting Heart Rate and Cardio Distance. This is the best way to gauge if the compound is active (your stats should improve rapidly).
Disclaimer:
This guide is for informational purposes only. SLU-PP-332 is an experimental compound.